This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Samyang Biopharmaceuticals Corporation. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Hye Sung Yoon in Antimicrobial Technology
Introduction
Hye Sung Yoon is a prominent inventor based in Daejeon, South Korea, recognized for his innovative work in antimicrobial technology. With a patent to his name, he has made significant strides in developing solutions that address critical health and safety challenges. His contributions are both impactful and essential in the medical field.
Latest Patents
Hye Sung Yoon holds a patent for a "Matrix Type Antimicrobial Vehicle and Manufacturing Method Thereof." This invention is designed to enhance the safety of medical kits and packages through its unique features. The matrix type antimicrobial vehicle includes a matrix layer containing an antimicrobial agent and adhesive, an antimicrobial agent-releasing layer on one surface, and a release liner on the other. This innovative design allows the continuous release of the antimicrobial agent, ensuring that medical kits or packages maintain a consistent concentration of the agent over extended storage periods.
Career Highlights
Yoon’s career is marked by his work at Samyang Biopharmaceuticals Corporation, where he has utilized his expertise to advance antimicrobial solutions. His dedication to research and development has positioned him as a key figure in the biopharmaceutical sector, contributing to the safety and effectiveness of medical products.
Collaborations
At Samyang Biopharmaceuticals Corporation, Yoon collaborates with talented coworkers like Hyun Kyoon Kim and Wang Soo Shin. Together, they work towards developing advanced biopharmaceutical products that prioritize health and safety, showcasing an impressive synergy among talented professionals.
Conclusion
Hye Sung Yoon's contributions to antimicrobial technology exemplify the importance of innovation in the biopharmaceutical field. His patent demonstrates a commitment to improving health outcomes through continuous research and collaboration. As he continues to push the boundaries of what is possible, his work will likely inspire further advancements in medical safety and efficacy.